Treatment & Management
Treatment and management services, including cognitive therapy, will start from May 30th, 2022. In the meantime, please visit some of the other sections of our website or sign up below already.
While a cure for dementia is still underway, there are medication and non-medication treatments that can help alleviate symptoms and slow cognitive decline. In addition, coordinated care with input from brain health experts plays an important role in optimizing overall brain health.
To maximize quality of life and independent functioning, treatments are directed at helping delay cognitive decline. The importance of delaying cognitive decline cannot be understated, especially in cases like dementia due to Alzheimer’s disease where delaying the onset by just 5 years could reduce your risk of getting it by 50%.
The main class of drugs currently used for the treatment of AD are acetylcholinesterase/ cholinesterase inhibitors. The three main medications that belong to this therapeutic class are donepezil, rivastigmine, and galantamine.
Cholinesterase inhibitors work by preventing the breakdown of acetylcholine, a chemical messenger that is important for memory and learning, thereby supporting communication between nerve cells. Donepezil is approved to treat all stages of Alzheimer’s disease. Rivastigmine is used for the treatment of mild-to-moderate Alzheimer’s as well as mild-to-moderate dementia associated with Parkinson’s disease. Galantamine, just like rivastigmine, is approved for mild-to-moderate stages of Alzheimer’s disease.
Another medication often used is memantine, which is partially inhibits NMDA receptors in the brain. NMDA receptors serve as mediators of neuronal injury associated with many neurological disorders that include ischemia, brain trauma, neurodegenerative disorders and dementia. Memantine is approved for moderate to severe AD and is being studied for alleviating other causes of cognitive decline like vascular dementia.
Non-pharmacological treatments have been shown to be as effective as pharmacological treatments in many cases. Besides addressing the risk factors of Alzheimer’s Disease and other causes of dementia, cognitive therapy (CT) is an effective form of treatment provided by speech language pathologists.
CT uses theme-based, mentally stimulating activities aimed to improve cognitive function. CT is designed to train specific parts of the brain, build cognitive reserve, and teach compensatory techniques to minimize the impact of cognitive decline on activities of daily living. It often works well in individuals with mild to moderate dementia as well in those with mild cognitive impairment.
The evidence is practical. In a data report by the American Speech-Language-Hearing Association (ASHA) assessing outpatient change in functional communication measures (like memory, spoken language, problem solving, and more), almost 72% of participants in cognitive treatment sessions experienced at least one level of improvement.
 American Speech-Language-Hearing Association National Outcomes Measurement Association. (2019). (rep). Adults in Healthcare – Outpatient 2019 (p. 36).
Monitoring and Surveillance
Monitoring and surveillance through cognitive assessments is a great way to track progression for diseases like Alzheimer’s. If one is concerned about changes in memory or experiences problems with thinking, it is always a great idea to consult a specialist like the brain health experts at Isaac Health.
Start with a free consultation*
*Consultation with care team is free. All other parts of diagnosis are covered as per your health insurance or Medicare coverage